share_log

Truist Securities Reiterates Buy on ANI Pharmaceuticals, Maintains $70 Price Target

Truist Securities Reiterates Buy on ANI Pharmaceuticals, Maintains $70 Price Target

Truist Securities重申买入ANI Pharmicals,维持70美元的目标价
Benzinga ·  2023/08/21 09:56

Truist Securities analyst Gregory Fraser reiterates ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and maintains $70 price target.

Truist Securities分析师格雷戈里·弗雷泽重申ANI Pharmicals(纳斯达克股票代码:ANIP)的买入并维持70美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发